Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain

Microbial Pathogenesis

Volumn 53, Issue 2, 2012, Pages 87-94

  Lucero, María Soledad ^a   Mirarchi, Federico ^a   Goldstein, Jorge ^a   Silberstein, Claudia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hemolytic uremic sydrome; Shiga toxin 2; Water channel

Indexed keywords

AQUAPORIN 1; AQUAPORIN 4; GLIAL FIBRILLARY ACIDIC PROTEIN; VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; LEG DISEASE; LETHARGY; MALE; NERVE INJURY; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SUPERNATANT;

ANIMALS; AQUAPORIN 1; AQUAPORIN 4; BRAIN; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SHIGA TOXIN 2;

ESCHERICHIA COLI; RATTUS;

EID: 84862755232     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.05.005     Document Type: Article

References (58)

1. Repetto H.A. Epidemic hemolytic-uremic syndrome in children. Kidney Int 1997, 52:1708-1719.
2. Repetto H.A. Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome. Kidney Int 2005, (Suppl. 97):S102-S106.
3. Eriksson K.J., Boyd S.G., Tasker R.C. Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch Dis Child 2001, 84(5):434-435.
4. Exeni R. Síndrome Urémico Hemolítico. Arch Latin Nefr Ped 2001, 1:35-56.
5. Oakes R.S., Siegler R.L., McReynolds M.A., Pysher T., Pavia A.T. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 2006, 117(5):1656-1662.
6. Gallo E.G., Gianantonio C.A. Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 1995, 9(1):117-119.
7. Siegler R.L. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 1994, 125(4):511-518.
8. Valles P.G., Pesle S., Piovano L., Davila E., Peralta M., Principi I., et al. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina 2005, 65:395-401.
9. Rivas M., Miliwebsky E., Chinen I., Deza N., Leotta G. The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina 2006, 66:27-32.
10. O'Brien A.D., Holmes R.K. Shiga and Shiga-like toxins. Microbiol Rev 1987, 51:206-220.
11. Lingwood C.A. Role of verotoxin receptors in pathogenesis. Trends Microbiol 1996, 4:147-153.
12. Sandvig K., Garred O., Prydz K., Kozlov J.V., Hansen S.H., van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992, 358:510-512.
13. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara K., Igarashi K. Site of action of a Vero toxin (VT2) from E coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988, 171:335-337.
14. Johannes L., Romer W. Shiga toxins-from cell biology to biomedical applications. Nat Rev Microbiol 2010, 8(2):105-116.
15. Obata F., Tohyama K., Bonev A.D., Kolling G.L., Keepers T.R., Gross L.K., et al. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 2008, 198:1398-1406.
16. Tironi-Farinati C., Loidl C.F., Boccoli J., Parma Y., Fernandez-Miyakawa M.E., Goldstein J. Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 2010, 222:48-61.
17. Goldstein J., Loid C.F., Pistone Creydt V., Boccoli J., Ibarra C. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glia alterations: an ultrastructural study. Brain Res 2007, 1161:106-115.
18. Tzipori S., Chow C.H., Powell H.R. Cerebral infection with Escherichia coli 01 57:H7 in humans and gnotobiotic piglets. J Clin Pathol 1988, 41:1099-1103.
19. Francis D.H., Moxley R.A., Andraos C.Y. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli Serotype 0157:H7. Infect Immun 1989, 57(4):1339-1342.
20. Isogai E., Isogai H., Kimura K., Hayashi S., Kubota T., Fujii N., et al. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157 :H7 strain. Infect Immun 1998, 66:197-202.
21. Lehmann G.L., Gradilone S.A., Marinelli R.A. Aquaporin water channels in central nervous system. Curr Neurovasc Res 2004, 1:293-303.
22. Yool A.J. Aquaporins: multiple roles in the central nervous system. Neuroscientist 2007, 13:470-485.
23. Zelenina M. Regulation of brain aquaporins. Neurochem Int 2010, 57:468-488.
24. Praetorius J., Nielsen S. Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol 2006, 291:C59-C67.
25. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., Bourque C., Agre P., Ottersen O.P. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17(1):171-180.
26. Lu M., Lee M.D., Smith B.L., Jung J.S., Agre P., Verdijk M.A., et al. The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain. Proc Natl Acad Sci U S A 1996, 93(20):10908-10912.
27. Furman C.S., Gorelick-Feldman D.A., Davidson K.G., Yasumura T., Neely J.D., Agre P., et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 2003, 100(23):13609-13614.
28. Silberstein C., Bouley R., Huang Y., Fang P., Pastor-Soler N., Brown D., et al. Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells. Am J Physiol Renal Physiol 2004, 287(3):F501-F511.
29. Amiry-Moghaddam M., Williamson A., Palomba M., Eid T., de Lanerolle N.C., Nagelhus E.A., et al. Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of a-syntrophin-null mice. Proc Natl Acad Sci U S A 2003, 100:13615-13620.
30. Verkman A.S., Binder D.K., Bloch O., Auguste K., Papadopoulos M.C. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochim Biophys Acta 2006, 1758(8):1085-1093.
31. Silberstein C., Lucero M.S., Zotta E., Copeland D.P., Lingyun L., Repetto H.A., et al. Glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of Shiga toxin-2. Pediatr Res 2011, 69(5):390-394.
32. Hall W.C. Upper motor neuron control of the brainstem and spinal cord. Neuroscience 2004, 393-415. Sinauer Associates Inc, Sunderland (MA):. 3rd ed. D. Purves, G.J. Augustine, D. Fitzpatrick, W.C. Hall, A.S. Lamantia, J.O. McNamara (Eds.).
33. Fukuda M., Kitaichi K., Abe F., Fujimoto Y., Takagi K., Morishima T., et al. Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice. J Pharmacol Sci 2005, 97:525-532.
34. Binder D.K., Oshio K., Ma T., Verkman A.S., Manley G.T. Increased seizure threshold in mice lacking aquaporin-4 water channels. Neuroreport 2004, 15:259-262.
35. Binder D.K., Yao X., Verkman A.S., Manley G.T. Increased seizure duration in mice lacking aquaporin-4 water channels. Acta Neurochir 2006, (Suppl. 96):389-392.
36. Oshio K., Watanabe H., Song Y., Verkman A.S., Manley G.T. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J 2005, 19(1):76-78.
37. Schnermann J., Chou C.-L., Ma T., Traynor T., Knepper M.A., Verkman A.S. Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice. Proc Natl Acad Sci U S A 1998, 95:9660-9664.
38. Ma T., Yang B., Gillespie A., Carlson E.J., Epstein C.J., Verkman A.S. Generation and phenotype of a transgenic knock-out mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 1997, 100:957-962.
39. Sugatani J., Komiyama N., Mochizuki T., Hoshino M., Miyamoto D., Igarashi T., et al. Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with poliuria. Life Sci 2002, 71:171-189.
40. Fujii J., Wood K., Matsuda F., Carneiro-Filho B.A., Schlegel K.H., Yutsudo T., et al. Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBPhomologous protein. Infect Immun 2008, 76:3679-3689.
41. Pistone Creydt V., Silberstein C., Zotta E., Ibarra C. Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 2006, 8:410-419.
42. Silberstein C., Pistone Creydt V., Gerhard E., Núñez P., Ibarra C. Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2. Pediatr Nephrol 2008, 23:1981-1990.
43. Rutjes N.W., Binnington B.A., Smith C.R., Maloney M.D., Lingwood C.A. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int 2002, 62:832-845.
44. Smith W.E., Kane A.V., Campbell S.T., Acheson D.W.K., Cochran B.H., Thorpe C.M. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect Immun 2003, 71:1497-1504.
45. Landoni V.I., de Campos-Nebel M., Schierloh P., Calatayud C., Fernandez G.C., Ramos M.V., et al. Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha. Infect Immun 2010, 78(3):1193-1201.
46. Petruzzielo-Pellegrini T.N., Yuen D.A., Page A.V., Patel S., Soltyk A.M., Matouk C.C., et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogeesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012, 122:759-775.
47. Zelenina M., Zelenin S., Bondar A.A., Brismar H., Aperia A. Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine. Am J Physiol Renal Physiol 2002, 283:F309-F318.
48. Kuppers E., Gleiser C., Brito V., Wachter B., Pauly T., Hirt B., et al. AQP4 expression in striatal primary cultures is regulated by dopamine-implications for proliferation of astrocytes. Eur J Neurosci 2008, 28:2173-2182.
49. Luo Y., Kokkonen G.C., Hattori A., Chrest F.J., Roth G.S. Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells. Brain Res 1999, 850:21-38.
50. Boccoli J., Loidl C.F., Lopez-Costa J.J., Creydt V.P., Ibarra C., Goldstein J. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res 2008, 1230:320-333.
51. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000, 20:131-147.
52. Pehar M., Cassina P., Vargas M.R., Castellanos R., Viera L., Beckman J.S., et al. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 2004, 89:464-473.
53. Ramegowda M., Samuel J., Tesh V. Interaction of shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis 1999, 180:1205-1213.
54. Eisenhauer P.B., Chaturvedi P., Fine R.E., Ritchie A.J., Pober J.S., Cleary T.G., et al. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 2001, 69:1889-1894.
55. Ito H., Yamamoto N., Arima H., Hirate H., Morishima T., Umenishi F., et al. Interleukin-1β induces the expression of aquaporin-4 through a nuclear factor-κß pathway in rat astrocytes. J Neurochem 2006, 99:107-118.
56. Satoh J., Tabunoki H., Yamamura T., Arima K., Konno H. Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology 2007, 27:245-256.
57. Fujii J., Kita T., Yoshida S., Takeda T., Kobayashi H., Tanaka N., et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H7 in mitomycin-treated mice. Infect Immun 1994, 62:3447-3453.
58. Fujii J., Kinoshita Y., Yamada Y., Yutsudo T., Kita T., Takeda T., et al. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. Microb Pathog 1998, 25:139-146.